The US FDA has approved Bristol-Myers’ lung cancer drug
The US Food and Drug Administration has approved Bristol-Myers Squibb’s lung cancer drug, which was acquired in a $4.1 billion buyout by Turning Point Therapeutics last year.
POPULAR POSTS
Trump opts for personal ties to choose his government team
November 15, 2024
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
LIVE STREAM
